Conjugation of a Water-Soluble Gadolinium Endohedral Fulleride with an Antibody as a Magnetic Resonance Imaging Contrast Agent

Water-soluble gadofullerides exhibited high efficiency as magnetic resonance imaging (MRI) contrast agents. In this paper, we report the conjugation of the newly synthesized gadofulleride, Gd@C82O6(OH)16(NHCH2CH2COOH)8, with the antibody of green fluorescence protein (anti-GFP), as a model for “tumo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioconjugate chemistry 2008-03, Vol.19 (3), p.651-655
Hauptverfasser: Shu, Chun-Ying, Ma, Xin-Yong, Zhang, Jian-Fei, Corwin, Frank D, Sim, Jae Hyun, Zhang, Er-Yun, Dorn, Harry C, Gibson, Harry W, Fatouros, Panos P, Wang, Chun-Ru, Fang, Xiao-Hong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Water-soluble gadofullerides exhibited high efficiency as magnetic resonance imaging (MRI) contrast agents. In this paper, we report the conjugation of the newly synthesized gadofulleride, Gd@C82O6(OH)16(NHCH2CH2COOH)8, with the antibody of green fluorescence protein (anti-GFP), as a model for “tumor targeted” imaging agents based on endohedral metallofullerenes. In this model system, the activity of the anti-GFP conjugate can be conveniently detected by green fluorescence protein (GFP), leading to in vitro experiments more direct and facile than those of tumor antibodies. Objective-type total internal reflection fluorescence microscopy revealed that each gadofulleride aggregate conjugated on average five anti-GFPs, and the activity of anti-GFPs was preserved after conjugation. In addition, the gadofulleride/antibody conjugate exhibited higher water proton relaxivity (12.0 mM−1 s−1) than the parent gadofulleride aggregate (8.1 mM−1 s−1) in phosphate buffered saline at 0.35 T, as also confirmed by T 1-weighted images of phantoms. These observations clearly indicate that the synthesized gadofulleride/antibody conjugate not only has targeting potential, but also exhibits higher efficiency as an MRI contrast agent.
ISSN:1043-1802
1520-4812
DOI:10.1021/bc7002742